Neurofit VR

Neurofit operates in digital health at the intersection of cognitive rehabilitation, clinical software, and therapeutics. Its stated product focus is a clinician-oriented digital platform that connects in-person care with remote and at-home practice. The described workflow combines assigned cognitive activities with measures such as accuracy, decision time, and completion, as well as mood and engagement check-ins; progress reports and clinic or funding letter exports are also part of the offering. This gives the product a more specific rehabilitation and care-coordination focus than a general wellness application, while its browser-based Neurofit Web experience lowers the need for clients to install software. Its profile instead places it among health diagnostics, medical, and therapeutics businesses. The company is privately held and its last recorded financing was a 2022 seed round with Techstars identified as an investor. Its differentiation is therefore best described through its clinician workflow and tracking features, not through demonstrated market leadership.

Neurofit’s recorded funding history begins with grants of $3,869 on Sep 21, 2018, $11,543 on Oct 15, 2018, and $37,495 on Jun 12, 2019. The company was founded in September 2019, and a pre-seed round is dated Jan 1, 2020. Its latest recorded financing is a seed round dated Sep 15, 2022, with Techstars listed as an investor; the recorded total funding is $52,907 USD. These events indicate early-stage financing, but the seed round is now several years old and does not establish continued fundraising or growth since then. Neurofit’s product direction is centered on extending cognitive rehabilitation beyond clinic visits through clinician-assigned activities, home-practice scheduling, check-ins, tracking, and reports. The product listing for Neurofit Web describes browser-based cognitive and behavioral assessment and therapy, while the company’s broader description also references web and virtual-reality experiences. The listed employee range is 11–50, but this is a broad band and should not be read as a precise headcount or evidence of hiring momentum. The evidence supports a trajectory from early grants and seed financing toward a digital rehabilitation workflow, while the pace and scale of more recent growth remain unclear.